查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423583

到 2030 年臨床決策支援系統市場預測：按產品類型、組件、型態、應用、最終用戶和地區進行的全球分析

Clinical Decision Support Systems Market Forecasts to 2030 - Global Analysis By Product Type, Component, Mode of Delivery, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球臨床決策支援系統市場規模將達到 17 億美元，預計到 2030 年將達到 32 億美元，預測期內複合年成長率為 9.5%。

臨床決策支援系統 (CDSS) 是一種基於電腦的工具或軟體，旨在透過在照護端提供相關資訊和知識來協助醫療保健專業人員做出臨床決策。這些系統整合了患者資料、醫學知識和最佳實踐，以提供建議、提醒和警報，以幫助診斷、治療和管理患者。目標是改善醫療保健結果、提高病人安全並支持臨床醫生提供更明智、更有效率的照護。

根據國家衛生資訊技術協調員辦公室 (ONC) 的數據，截至 2021 年，美國約 96% 的非聯邦急診醫院和近五分之四 (78%) 的執業醫生獲得了認證。引入了電子健康記錄（EHR）系統。

對優質醫療保健的需求不斷成長

對提供優質醫療保健的日益關注正在增加市場需求。隨著醫療保健變得越來越複雜，CDSS 正在成為幫助臨床醫生做出明智決策、改善患者治療結果並減少錯誤的重要解決方案。市場擴張反映出醫療保健系統內對先進技術整合的需求不斷成長，從而實現高效的資料分析、個人化的患者照護、簡化的決策流程以及更高的醫療保健服務標準。

資料品質和可訪問性

在這個市場中，人們不斷強調資料的準確性、完整性和可訪問性，以確保最佳的系統功能。這包括整合不同的資料來源、實施強大的檢驗流程以及優先考慮互通性以實現無縫資訊交流。對資料品質和可訪問性的關注對於這一演變至關重要，因為它增強了醫療保健專業人員的信心，並使他們能夠做出越來越明智的臨床決策。這些都是限制市場成長的因素。

提高資料可用性

醫療技術、互通性標準和數位健康記錄的進步正在迅速提高資料的可用性。這種湧入包含了不同的患者資料，包括基因組資訊、即時監測和全面的病歷。更輕鬆地存取資料使這些系統能夠提供更準確和個人化的建議，改善醫療保健結果，同時提高臨床決策流程的效率和準確性。促進改進治療策略。

成本和資源限制

發展需要對先進技術、熟練的人力資源和大量臨床資料進行大量投資。實施涉及客製化成本、與現有醫療保健系統的整合以及持續維護的成本。資源限制（包括獲取高品質資料和演算法開發專業知識）阻礙了 CDSS 的可擴展性和創新。平衡成本效益和最佳功能是這個市場的主要障礙。

COVID-19 的影響：

COVID-19 大流行顯著加速了全球臨床決策支援系統 (CDSS) 的採用和開發。對遠端醫療和遠距醫療保健服務的依賴增加增加了對先進 CDSS 的需求，從而推動了市場成長。這些系統可協助醫療保健專業人員管理患者資料、提高診斷準確性和最佳化治療計劃。此次疫情凸顯了高效、資料驅動的醫療保健解決方案的重要性，從而推動了該領域的市場擴張和創新。

在預測期內，互操作系統領域預計將是最大的。

預計互操作系統領域在預測期內將是最大的。這些系統優先考慮相容性，並允許不同的醫療保健軟體有效地進行通訊。互通性確保患者資訊的順利交換並提高臨床決策的準確性和效率。市場趨勢集中在 CDSS 解決方案上，這些解決方案可以與各種醫療保健技術互連，以最佳化資料利用以實現明智的醫療干預。

藥物過敏警告部分預計在預測期內複合年成長率最高

藥物過敏警報部分預計在預測期內複合年成長率最高。這些系統的主要優點之一是許多人對某些藥物過敏，因此提供過敏警報的能力變得越來越重要。經歷藥物過敏的患者數量正在增加。結果，它會對接受藥物的患者產生負面影響，並使患者的病情進一步惡化。

比最大的地區

由於醫療產業對資訊科技解決方案的需求不斷增加，預計北美在預測期內將佔據最大的市場佔有率。提供優質醫療保健的重要性日益增加，快速的技術進步也促進了該地區的市場成長。科技的快速開拓以及提供優質醫療服務的重要性日益增加也推動了該地區的市場擴張。

複合年成長率最高的地區：

由於主要政府研發支出的增加，預計亞太地區在預測期內將維持最高的複合年成長率。印度、中國、日本和澳洲等國家對醫療保健領域的投資正在增加。研究和開發技術的改進以及政府在該領域的支出和投資是提高資訊科技在醫療產業滲透率的原因。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球臨床決策支援系統市場：依產品類型

  • 知識庫系統
  • 非知識型系統
  • 互操作系統
  • 其他產品類型

第6章全球臨床決策支援系統市場：依組成部分

  • 軟體
  • 硬體
  • 服務

第7章全球臨床決策支援系統市場：依交付型態

  • 本地
  • 基於網路的
  • 雲端基礎

第8章全球臨床決策支援系統市場：依應用分類

  • 關於藥物過敏的警告
  • 藥物間相互作用
  • 臨床提醒
  • 臨床指引
  • 藥物支持
  • 其他用途

第9章全球臨床決策支援系統市場：依最終使用者分類

  • 藥局
  • 醫院
  • 診所
  • 診斷中心
  • 門診手術中心
  • 其他最終用戶

第10章全球臨床決策支援系統市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司簡介

  • McKesson Corporation
  • Koninklijke Philips NV
  • Cerner Corporation
  • Allscripts Healthcare, LLC
  • Siemens Healthineers GmbH
  • NextGen Healthcare Inc.
  • Wolters Kluwer NV
  • Agfa-Gevaert Group
  • Athenahealth, Inc.
  • IBM Corporation
  • Change Healthcare
  • Meditech
  • Epic Systems Corporation
  • Carestream
Product Code: SMRC24817

According to Stratistics MRC, the Global Clinical Decision Support Systems Market is accounted for $1.7 billion in 2023 and is expected to reach $3.2 billion by 2030 growing at a CAGR of 9.5% during the forecast period. Clinical Decision Support Systems (CDSS) are computer-based tools or software designed to assist healthcare professionals in making clinical decisions by providing relevant information and knowledge at the point of care. These systems integrate patient data, medical knowledge, and best practices to offer recommendations, reminders, or alerts to aid in diagnosis, treatment, and management of patients. The goal is to improve healthcare outcomes, enhance patient safety, and support clinicians in delivering more informed and efficient care.

According to The Office of the National Coordinator for Health Information Technology (ONC), as of 2021, in the US approximately 96 percent of non-federal acute care hospitals and nearly 4 in 5 office-based physicians (78%) have implemented a certified Electronic Health Record (EHR) system.

Market Dynamics:

Driver:

Rising demand for quality healthcare

The market experiences escalating demand owing to a growing emphasis on superior healthcare provision. As healthcare complexities rise, CDSS emerges as a critical solution, aiding clinicians in making informed decisions, improving patient outcomes, and reducing errors. The market's expansion reflects the increasing need for advanced technology integration within healthcare systems, enabling efficient data analysis, personalized patient care, and streamlined decision-making processes, fostering a higher standard of healthcare delivery.

Restraint:

Data quality and accessibility

The market continually emphasizes enhancing data accuracy, completeness, and accessibility to ensure optimal system functionality. This involves integrating diverse data sources, implementing robust validation processes, and prioritizing interoperability for seamless information exchange. As it evolves, emphasis on data quality and accessibility remains pivotal, fostering trust among healthcare professionals and enabling informed, precise clinical decisions. These are the factors restraining the growth of the market.

Opportunity:

Increasing data availability

The market is witnessing a surge in data availability, catalyzed by advancements in health tech, interoperability standards, and digital health records. This influx encompasses diverse patient data, including genomic information, real-time monitoring, and comprehensive medical histories. Enhanced data accessibility empowers these systems to offer more precise, personalized recommendations, fostering improved healthcare outcomes and treatment strategies while promoting efficiency and accuracy in clinical decision-making processes.

Threat:

Costs and resource constraints

Development demands substantial investment in advanced technology, skilled personnel, and extensive clinical data. Implementation incurs expenses related to customization, integration with existing healthcare systems, and ongoing maintenance. Resource limitations, including access to high-quality data and expertise in algorithm development, hinder CDSS scalability and innovation. Balancing cost-effectiveness with optimal functionality poses a significant hurdle in this market.

Covid-19 Impact:

The COVID-19 pandemic significantly accelerated the adoption and development of Clinical Decision Support Systems (CDSS) globally. The increased reliance on telemedicine and remote healthcare services amplified the need for advanced CDSS, driving market growth. These systems aided healthcare professionals in managing patient data, improving diagnostic accuracy, and optimizing treatment plans. The pandemic highlighted the importance of efficient and data-driven healthcare solutions, leading to an expansion in the market and innovation in this sector.

The interoperable systems segment is expected to be the largest during the forecast period

The interoperable systems segment is expected to be the largest during the forecast period. These systems prioritize compatibility, enabling diverse healthcare software to communicate effectively. Interoperability ensures fluid exchange of patient information, enhancing accuracy and efficiency in clinical decision-making. The market trend emphasizes CDSS solutions that can interconnect with various healthcare technologies, optimizing data utilization for informed medical interventions.

The drug allergy alerts segment is expected to have the highest CAGR during the forecast period

The drug allergy alerts segment is expected to have the highest CAGR during the forecast period. One major benefit of these systems is that their ability to deliver allergy alerts is becoming more and more significant, as many people have allergies to particular medications. The number of patients experiencing medication allergies is on the rise. As a result, giving medication to a patient who has been given it may have negative effects and further damage the patient's case.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to the increasing demand for information technology solutions in the health care industry. There's an increased importance for providing quality healthcare and rapid technological advancements these factors help in providing for the growth of the market in this region. The market expansion in this area is also fueled by the quick development of technology and the growing significance of offering high-quality healthcare services.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to increased R&D spending by governments of key nations. There are increasing investments in the healthcare sector in various countries like India China Japan and Australia. Improved research and development techniques and the expenditure and investments by the government in this field are the reasons which are helping increasing the penetration of information technology in the medical industry.

Key players in the market

Some of the key players in Clinical Decision Support Systems market include McKesson Corporation, Koninklijke Philips N.V., Cerner Corporation, Allscripts Healthcare, LLC, Siemens Healthineers GmbH, NextGen Healthcare Inc., Wolters Kluwer N.V., Agfa-Gevaert Group, Athenahealth, Inc., IBM Corporation, Change Healthcare, Meditech, Epic Systems Corporation, and Carestream.

Key Developments:

In April 2023, Elsevier B.V. (UK) announced the launch of an upgraded version of its clinical decision support solution, ClinicalKey. This enhanced platform incorporates a comprehensive drug compendium, a cutting-edge mobile application, and seamless integration into Electronic Health Records (EHR).

In December 2022, Athenahealth (US) announced that it had released enhancements to its athenaOne EHR to facilitate immediate administration of COVID-19 vaccines. The rollout includes communications, scheduling, workflow, documentation, and reporting capabilities.

In April 2022, Change Healthcare (US) launched a new edition of InterQual 2022, the firm's flagship clinical decision support solution for delivering the latest evidence-based appropriate care.

Product Types Covered:

  • Knowledge-Based Systems
  • Non-Knowledge-Based Systems
  • Interoperable Systems
  • Other Product Types

Components Covered:

  • Software
  • Hardware
  • Services

Mode of Deliveries Covered:

  • On Premise
  • Web Based
  • Cloud Based

Applications Covered:

  • Drug Allergy Alerts
  • Drug-Drug Interactions
  • Clinical Reminders
  • Clinical Guidelines
  • Drug Dosing Support
  • Other Applications

End Users Covered:

  • Pharmacies
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Ambulatory Surgical Centres
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Clinical Decision Support Systems Market, By Product Type

  • 5.1 Introduction
  • 5.2 Knowledge-Based Systems
  • 5.3 Non-Knowledge-Based Systems
  • 5.4 Interoperable Systems
  • 5.5 Other Product Types

6 Global Clinical Decision Support Systems Market, By Component

  • 6.1 Introduction
  • 6.2 Software
  • 6.3 Hardware
  • 6.4 Services

7 Global Clinical Decision Support Systems Market, By Mode of Delivery

  • 7.1 Introduction
  • 7.2 On Premise
  • 7.3 Web Based
  • 7.4 Cloud Based

8 Global Clinical Decision Support Systems Market, By Application

  • 8.1 Introduction
  • 8.2 Drug Allergy Alerts
  • 8.3 Drug-Drug Interactions
  • 8.4 Clinical Reminders
  • 8.5 Clinical Guidelines
  • 8.6 Drug Dosing Support
  • 8.7 Other Applications

9 Global Clinical Decision Support Systems Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmacies
  • 9.3 Hospitals
  • 9.4 Clinics
  • 9.5 Diagnostic Centers
  • 9.6 Ambulatory Surgical Centres
  • 9.7 Other End Users

10 Global Clinical Decision Support Systems Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 McKesson Corporation
  • 12.2 Koninklijke Philips N.V.
  • 12.3 Cerner Corporation
  • 12.4 Allscripts Healthcare, LLC
  • 12.5 Siemens Healthineers GmbH
  • 12.6 NextGen Healthcare Inc.
  • 12.7 Wolters Kluwer N.V.
  • 12.8 Agfa-Gevaert Group
  • 12.9 Athenahealth, Inc.
  • 12.10 IBM Corporation
  • 12.11 Change Healthcare
  • 12.12 Meditech
  • 12.13 Epic Systems Corporation
  • 12.14 Carestream

List of Tables

  • Table 1 Global Clinical Decision Support Systems Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Clinical Decision Support Systems Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Clinical Decision Support Systems Market Outlook, By Knowledge-Based Systems (2021-2030) ($MN)
  • Table 4 Global Clinical Decision Support Systems Market Outlook, By Non-Knowledge-Based Systems (2021-2030) ($MN)
  • Table 5 Global Clinical Decision Support Systems Market Outlook, By Interoperable Systems (2021-2030) ($MN)
  • Table 6 Global Clinical Decision Support Systems Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 7 Global Clinical Decision Support Systems Market Outlook, By Component (2021-2030) ($MN)
  • Table 8 Global Clinical Decision Support Systems Market Outlook, By Software (2021-2030) ($MN)
  • Table 9 Global Clinical Decision Support Systems Market Outlook, By Hardware (2021-2030) ($MN)
  • Table 10 Global Clinical Decision Support Systems Market Outlook, By Services (2021-2030) ($MN)
  • Table 11 Global Clinical Decision Support Systems Market Outlook, By Mode of Delivery (2021-2030) ($MN)
  • Table 12 Global Clinical Decision Support Systems Market Outlook, By On Premise (2021-2030) ($MN)
  • Table 13 Global Clinical Decision Support Systems Market Outlook, By Web Based (2021-2030) ($MN)
  • Table 14 Global Clinical Decision Support Systems Market Outlook, By Cloud Based (2021-2030) ($MN)
  • Table 15 Global Clinical Decision Support Systems Market Outlook, By Application (2021-2030) ($MN)
  • Table 16 Global Clinical Decision Support Systems Market Outlook, By Drug Allergy Alerts (2021-2030) ($MN)
  • Table 17 Global Clinical Decision Support Systems Market Outlook, By Drug-Drug Interactions (2021-2030) ($MN)
  • Table 18 Global Clinical Decision Support Systems Market Outlook, By Clinical Reminders (2021-2030) ($MN)
  • Table 19 Global Clinical Decision Support Systems Market Outlook, By Clinical Guidelines (2021-2030) ($MN)
  • Table 20 Global Clinical Decision Support Systems Market Outlook, By Drug Dosing Support (2021-2030) ($MN)
  • Table 21 Global Clinical Decision Support Systems Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 22 Global Clinical Decision Support Systems Market Outlook, By End User (2021-2030) ($MN)
  • Table 23 Global Clinical Decision Support Systems Market Outlook, By Pharmacies (2021-2030) ($MN)
  • Table 24 Global Clinical Decision Support Systems Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 25 Global Clinical Decision Support Systems Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 26 Global Clinical Decision Support Systems Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 27 Global Clinical Decision Support Systems Market Outlook, By Ambulatory Surgical Centres (2021-2030) ($MN)
  • Table 28 Global Clinical Decision Support Systems Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.